Natural Killer (NK) cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Natural Killer (NK) cell therapy, covering 2024-04-02 to 2024-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Natural Killer(NK) Cell Combined With Programmed Death-1(PD-1) Antibody as Second Line Therapy for Advanced Driver Mutation Negative Non-small Cell Lung Cancer [Phase 2]